Jushi Holdings (JUSHF) EBT (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly EBT came in at -$11.1 million in Q1 2026, down 38.48% year-on-year from -$18.1 million in Q1 2025, and down 34.05% on a QoQ basis from -$8.3 million in Q4 2025.
Jushi Holdings (JUSHF) EBT (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of EBT data on file, last reported at -$11.1 million in Q1 2026.
- On a quarterly basis, EBT fell 38.48% year-over-year to -$11.1 million in Q1 2026; TTM through Mar 2026 was -$36.7 million, a 121.38% decrease from a year earlier, with the FY2025 full-year figure at -$33.6 million, down 95.97% from the prior year.
- EBT for Q1 2026 stood at -$11.1 million, down from -$8.3 million in the prior quarter.
- Over the last five years, EBT for JUSHF reached as high as $19.8 million in Q2 2022 and fell as low as -$141.4 million in Q4 2022.
- Historically, EBT has averaged -$17.0 million across 5 years, with a median of -$8.6 million in 2024.
- Across the five-year window, EBT slumped 1054.18% in 2022 and jumped 234.63% in 2024, its largest moves.
- Year by year, EBT stood at -$141.4 million in 2022, then surged by 90.88% to -$12.9 million in 2023, then jumped by 31.19% to -$8.9 million in 2024, then increased by 6.49% to -$8.3 million in 2025, then tumbled by 34.05% to -$11.1 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$11.1 million in Q1 2026, -$8.3 million in Q4 2025, and -$14.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | -11.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.13 Mn |
| Dec 31, 2025 | -8.30 Mn |
| Sep 30, 2025 | -14.86 Mn |
| Jun 30, 2025 | -2.40 Mn |
| Mar 31, 2025 | -8.04 Mn |
| Dec 31, 2024 | -8.88 Mn |
| Sep 30, 2024 | -7.05 Mn |
| Jun 30, 2024 | 7.39 Mn |
| Mar 31, 2024 | -8.61 Mn |
| Dec 31, 2023 | -12.90 Mn |
| Sep 30, 2023 | -12.61 Mn |
| Jun 30, 2023 | -5.49 Mn |
| Mar 31, 2023 | -2.29 Mn |
| Dec 31, 2022 | -141.45 Mn |
| Sep 30, 2022 | -57.50 Mn |
| Jun 30, 2022 | 19.78 Mn |
| Mar 31, 2022 | -14.71 Mn |
| Dec 31, 2021 | 14.82 Mn |
| Sep 30, 2021 | 46.02 Mn |
| Jun 30, 2021 | 9.00 Mn |